Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Imaging Depression in Parkinson's Disease

Study ID: NCT06402955
Start Date: 2025-12-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

11C-UCB-J

ketamine hydrochloride

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Study ID: NCT07221474
Start Date: 2025-12-02
End Date: 2031-05-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

V940

Pembrolizumab

Carboplatin

Paclitaxel

Nab-paclitaxel

Placebo

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Study ID: NCT07188558
Start Date: 2026-01
End Date: 2032-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

rondecabtagene autoleucel

axicabtagene ciloleucel

lisocabtagene maraleucel

Sponsor

Lyell Immunopharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Study ID: NCT02988297
Start Date: 2026-10
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

140

Intervention / Treatment

RNS60

Placebo

Sponsor

Revalesio Corporation

Source: clinicaltrials.gov

Share:
Add to list

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Study ID: NCT06716021
Start Date: 2026-01
End Date: 2029-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

750

Intervention / Treatment

Placebo

Etripam

Sponsor

Milestone Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

Scaling Out S.A.F.E. Firearm Across Two Health Systems as a Universal Suicide Prevention Strategy (SCALE ASPIRE)

Study ID: NCT07009314
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5442

Intervention / Treatment

Implementation package (training, facilitation, electronic health record nudge)

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Study ID: NCT06744816
Start Date: 2026-06-05
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Qutenza Patch

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

Study ID: NCT07102043
Start Date: 2025-12-01
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Study ID: NCT06488846
Start Date: 2026-01-15
End Date: 2027-09-29
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

INVITE-Home

Clinic-Administered LAI-ART

Oral ART

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Near Remote Method to Guide Performance of Regional Anesthesia

Study ID: NCT05968261
Start Date: 2026-01
End Date: 2026-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Real time 'near remote' guidance of regional blocks

Sponsor

Dr. Glenio Mizubuti (MD, PhD)

Source: clinicaltrials.gov

Share:
Add to list